Zipeng Lu
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
Papers in
- Oncology 51
- Pancreatic and Hepatic Oncology Research 42
- Cancer Cells and Metastasis 4
-
- RNA modifications and cancer 6
- Co-authors
- Yi Miao (69 shared papers)Kuirong Jiang (69 shared papers)Jishu Wei (35 shared papers)Pengfei Wu (20 shared papers)Baobao Cai (21 shared papers)Lei Tian (11 shared papers)Hao Yuan (9 shared papers)Jie Yin (16 shared papers)
- Journals
- Pancreatology (7 papers)Medicine (4 papers)Frontiers in Oncology (4 papers)Oncotarget (4 papers)Langenbeck s Archives of Surgery (4 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Zipeng Lu
97 papers receiving 2.3k citations
Zipeng Lu's Hit Papers
Peers
Comparison fields: 5 of 110
- Cancer Research 739
- Oncology 771
- Immunology 391
- Molecular Biology 1.2k
- Surgery 223
Countries citing papers authored by Zipeng Lu
This map shows the geographic impact of Zipeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zipeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zipeng Lu more than expected).
Fields of papers citing papers by Zipeng Lu
This network shows the impact of papers produced by Zipeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zipeng Lu. The network helps show where Zipeng Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Zipeng Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 212 | |
| 2 | 2011 | 142 | |
| 3 | 2019 | 126 | |
| 4 | Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer Hit paper breakdown → | 2024 | 123 |
| 5 | 2019 | 98 | |
| 6 | 2018 | 98 | |
| 7 | 2021 | 97 | |
| 8 | 2021 | 93 | |
| 9 | 2012 | 92 | |
| 10 | 2014 | 79 | |
| 11 | 2018 | 74 | |
| 12 | 2017 | 63 | |
| 13 | 2017 | 57 | |
| 14 | 2021 | 55 | |
| 15 | 2011 | 51 | |
| 16 | 2014 | 45 | |
| 17 | 2015 | 42 | |
| 18 | 2021 | 38 | |
| 19 | 2022 | 37 | |
| 20 | 2023 | 36 |
About Zipeng Lu
Zipeng Lu is a scholar working on Oncology, Molecular Biology, Surgery, Cancer Research and Immunology, having authored 103 papers that have together received 2.3k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (42 papers), Pancreatitis Pathology and Treatment (10 papers), Cancer-related molecular mechanisms research (8 papers), Phagocytosis and Immune Regulation (6 papers), RNA modifications and cancer (6 papers), Renal cell carcinoma treatment (4 papers), Galectins and Cancer Biology (4 papers) and Cancer Cells and Metastasis (4 papers). The work is most often cited by research in Cancer Research (739 citations), Oncology (771 citations), Immunology (391 citations), Molecular Biology (1.2k citations) and Surgery (223 citations). Zipeng Lu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yi Miao, Kuirong Jiang, Jishu Wei, Pengfei Wu, Baobao Cai, Lei Tian, Hao Yuan, Jie Yin, Wentao Gao and Min Tu. Their work appears in journals such as Pancreatology, Medicine, Frontiers in Oncology, Oncotarget and Langenbeck s Archives of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.